For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...

AUD/USD extends its consolidative price move and remains below the 0.6300 mark on Friday amid mixed cues. Bets that the RBA ...

NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

Ebola is rare, deadly and has multiple variations. There is a vaccine for the Zaire type, now trials for another are underway ...

If you suffered losses exceeding $75,000 in GSK between February 5, 2020 and August 14, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

A new method has been created for determining N-nitrosamines (NAs) in pharmaceutical preparations using liquid chromatography ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE: GSK) for violations of §§10 (b) and 20 ...

EUR/USD corrects to near 1.0360 in Thursday’s North American session. The major currency pair drops as the US Dollar (USD) ...

Japan’s rising household spending and wage growth boost BoJ rate hike bets, pressuring USD/JPY. US jobs data now in focus for ...

Patrick R. O'Neil, Executive Vice President, Chief Legal Officer & General Counsel of Ionis Pharmaceuticals Inc. (NASDAQ:IONS), recently sold 6,165 shares of the company's common stock. The shares ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...

BIO CEO & Investor Conference Format: "IPO Class of 2024 Panel" and one-on-one meetings Date: February 10, 2025 Location: New York, NY Registered conference attendees may schedule one-on-one meetings ...